Trexquant Investment’s Bristol-Myers Squibb BMY Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | $26M | Sell |
428,302
-378,433
| -47% | -$22.1M | 0.19% | 100 |
|
|
2025
Q4 | $43.5M | Sell |
806,735
-208,692
| -21% | -$10M | 0.39% | 22 |
|
|
2025
Q3 | $45.8M | Buy |
1,015,427
+826,660
| +438% | +$38.6M | 0.47% | 17 |
|
|
2025
Q2 | $8.74M | Buy |
+188,767
| New | +$9.27M | 0.1% | 297 |
|
|
2024
Q4 | – | Sell |
-47,114
| Closed | -$2.44M | – | 1563 |
|
|
2024
Q3 | $2.44M | Buy |
+47,114
| New | +$2.21M | 0.03% | 737 |
|
|
2023
Q4 | – | Sell |
-154,943
| Closed | -$8.99M | – | 1442 |
|
|
2023
Q3 | $8.99M | Sell |
154,943
-222,379
| -59% | -$13.6M | 0.23% | 97 |
|
|
2023
Q2 | $24.1M | Buy |
+377,322
| New | +$25.3M | 0.63% | 12 |
|
|
2023
Q1 | – | Sell |
-89,746
| Closed | -$6.46M | – | 1454 |
|
|
2022
Q4 | $6.46M | Buy |
+89,746
| New | +$6.77M | 0.18% | 148 |
|
|
2022
Q3 | – | Sell |
-11,799
| Closed | -$909K | – | 1378 |
|
|
2022
Q2 | $909K | Buy |
+11,799
| New | +$899K | 0.04% | 553 |
|
|
2021
Q4 | – | Sell |
-54,366
| Closed | -$3.22M | – | 1313 |
|
|
2021
Q3 | $3.22M | Buy |
54,366
+50,906
| +1,471% | +$3.35M | 0.26% | 96 |
|
|
2021
Q2 | $231K | Buy |
+3,460
| New | +$226K | 0.02% | 837 |
|
|
2021
Q1 | – | Sell |
-59,252
| Closed | -$3.67M | – | 1129 |
|
|
2020
Q4 | $3.67M | Sell |
59,252
-31,104
| -34% | -$1.91M | 0.39% | 56 |
|
|
2020
Q3 | $5.45M | Buy |
90,356
+63,456
| +236% | +$3.82M | 0.35% | 51 |
|
|
2020
Q2 | $1.58M | Buy |
+26,900
| New | +$1.61M | 0.11% | 261 |
|
|
2019
Q2 | – | Sell |
-117,127
| Closed | -$5.59M | – | 824 |
|
|
2019
Q1 | $5.59M | Buy |
117,127
+33,752
| +40% | +$1.68M | 0.4% | 46 |
|
|
2018
Q4 | $4.33M | Buy |
83,375
+3,418
| +4% | +$184K | 0.27% | 101 |
|
|
2018
Q3 | $4.96M | Buy |
+79,957
| New | +$4.74M | 0.37% | 67 |
|
|
2018
Q2 | – | Sell |
-64,073
| Closed | -$4.05M | – | 913 |
|
|
2018
Q1 | $4.05M | Buy |
+64,073
| New | +$4.12M | 0.28% | 76 |
|
|
2017
Q4 | – | Sell |
-3,522
| Closed | -$224K | – | 1049 |
|
|
2017
Q3 | $224K | Sell |
3,522
-478
| -12% | -$27.9K | 0.06% | 580 |
|
|
2017
Q2 | $223K | Buy |
+4,000
| New | +$218K | 0.06% | 615 |
|
|
2017
Q1 | – | Sell |
-3,900
| Closed | -$228K | – | 1081 |
|
|
2016
Q4 | $228K | Sell |
3,900
-16,400
| -81% | -$897K | 0.04% | 765 |
|
|
2016
Q3 | $1.09M | Buy |
+20,300
| New | +$1.3M | 0.24% | 116 |
|
|
2015
Q4 | – | Sell |
-9,700
| Closed | -$574K | – | 1016 |
|
|
2015
Q3 | $574K | Buy |
+9,700
| New | +$615K | 0.05% | 666 |
|
|
2015
Q2 | – | Sell |
-41,300
| Closed | -$2.66M | – | 991 |
|
|
2015
Q1 | $2.66M | Buy |
+41,300
| New | +$2.59M | 0.27% | 42 |
|
Other funds holding BMY
VCM
VPM
Trexquant Investment's BMY Position: Q1 2026 in Review
Trexquant Investment reduced its Bristol-Myers Squibb (BMY) stake by 47% in Q1 2026, selling an estimated $22.1M and leaving 428,302 shares worth $26M. The position accounts for 0.19% of the portfolio, ranked #100.
Trexquant Investment first reported a position in BMY in Q1 2015 and has held it in 24 quarters since. The position peaked at $45.8M in Q3 2025. 2,517 funds tracked by Wall St. Rank hold BMY as of Q1 2026.
- Trexquant Investment held 428,302 shares of Bristol-Myers Squibb worth $26M as of Q1 2026.
- Trexquant Investment sold 378,433 Bristol-Myers Squibb shares in Q1 2026, an estimated $22.1M.
- Bristol-Myers Squibb made up 0.19% of Trexquant Investment's portfolio in Q1 2026, its #100 holding.
- Trexquant Investment first reported a position in Bristol-Myers Squibb in Q1 2015 and has held it in 24 quarters since.
- Trexquant Investment's Bristol-Myers Squibb position peaked at $45.8M in Q3 2025.
- 2,517 funds tracked by Wall St. Rank held Bristol-Myers Squibb as of Q1 2026.
Based on Trexquant Investment's 13F filing for Q1 2026, filed 15 May 2026.